Filament Health targets substance use disorders with natural psychedelics
Filament Health Corp (OTCQB:FLHLF)'s diversified business model makes it one of the only psychedelics companies to be already generating revenue. The...
Stay updated with breaking news from Special Access Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Filament Health Corp (OTCQB:FLHLF)'s diversified business model makes it one of the only psychedelics companies to be already generating revenue. The...
Canadian not-for-profit organization TheraPsil has received board approval to launch its training program on MDMA-assisted psychotherapy for trauma survivors.
“People are going to have their medically-assisted death covered [by government funding], but they won’t have their psilocybin therapy covered.”
Health Canada has approved an amendment to Optimi Health’s (OTCQX: OPTHF) dealer's license, effectively allowing the company to supply MDMA and psilocybin drugs to the country’s Special Access Program (SAP.)
Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) is celebrating the successful implantation of its new class of biomimetic valves, the world’s only...